Terecoasa, Elena; Tiu, Cristina; Huertas, Nuria; de Leciñana, Maria Alonso
February 2012
Romanian Journal of Neurology;2012, Vol. 11 Issue 1, p13
Academic Journal
Intracranial hemorrhage (ICH) is the most feared and devastating complication of oral anticoagulant therapy. When an ICH occurs, the patient's situation hinges on the balance between how great is the embolic risk while not receiving anticoagulants, and how big is the threat of the hemorrhage if the anticoagulant effect is not reversed promptly. Although several studies which compared the use of different reversal agents failed to demonstrate any improvement in prognosis and survival, at the present moment the consensus seem to be that anticoagulation should be rapidly reversed after an ICH. The second question to be answered is whether and when should be oral anticoagulation treatment restarted. Although the risk of thromboembolism in patients off anticoagulation seems to be higher than the risk of ICH recurrence, there is a marked paucity of prospective large studies on the real risk of ICH recurrence when OAC is resumed, paucity that probably emphasizes the ethical challenge of prescribing patients a medication to which they have an apparent contraindication. The little evidence available suggests that the optimal time for resumption is between 10 days and 30 weeks.


Related Articles

  • THE PREVENTION OF THROMBOEMBOLISM. Loewe, Leo; Berger, Louis; Lasser, Richard P. // Angiology;Feb1951, Vol. 2 Issue 1, p26 

    1. Our experiences with an extensive prophylactic program for the prevention of thromboembolic disease have been related. The study has indicated that a mass program can be applied to a great variety of disease states with gratifying results. 2. Repository heparin has been found to be the drug...

  • Fragmin.  // Royal Society of Medicine: Medicines;2002, p257 

    The article presents information on fragmin. The drug is a proprietary, prescription-only preparation of the dalteparin sodium, which is a low molecular weight version of heparin. It can be used for long-duration prevention of venous thrombo-embolism, particularly in orthopaedic use, It is...

  • The dangers of stopping clopidogrel perioperatively: a cardiologist's perspective. Cleanthis, M.; Flather, Marcus // Clinical Risk;May2009, Vol. 15 Issue 3, p106 

    The article comments on the dangers of discontinuing the use of anti-platelets like clopidogrel. According to the author, anti-platelets increase bleeding risk, but they also cut the risk of arterial occlusion in the cerebral and cardiac vasculature. It is stated that bleeding risk would lead to...

  • Efficacy and safety of dabigatran in a "real-life" population at high thromboembolic and hemorrhagic risk: data from MonaldiCare registry. RUSSO, V.; BIANCHI, V.; CAVALLARO, C.; VECCHIONE, F.; DE VIVO, S.; SANTANGELO, L.; SARUBBI, B.; CALABRÒ, P.; NIGRO, G.; D'ONOFRIO, A. // European Review for Medical & Pharmacological Sciences;2015, Vol. 19 Issue 20, p3961 

    OBJECTIVE: Dabigatran is a novel target specific oral anticoagulant for stroke prevention in non valvular atrial fibrillation. Little is still known about its real-world effectiveness and safety in the italian population. Aim of our study was to evaluate the efficacy and safety of dabigatran in...

  • ABSTRACTS.  // Geriatrics;Aug1990, Vol. 45 Issue 8, p86 

    The article presents certain abstracts of research papers on geriatrics. One research paper shows that anticoagulants prevent stroke in patients with atrial fibrillation. Therapy with either aspirin or warfarin prevents ischemic stroke and systemic embolism in patients with atrial fibrillation...

  • PERIPHERAL ARTERIAL EMBOLISM. Haimovici, Henry // Angiology;Feb1950, Vol. 1 Issue 1, p20 

    The article cites several studies related to peripheral arterial embolism. Ever since 1911, when the first successful embolectomy was performed, there has been a steadily growing literature on peripheral arterial embolism. From then until 1934, embolectomy was considered the only weapon against...

  • PERIPHERAL ARTERIAL EMBOLISM. Mc. Cook, J.; Uguet, E.; Llabes, P.; Brunet, P.; Charles, D.; Beauballet, P.; Crespo, L. // Angiology;Jun1959, Vol. 10 Issue 3, p165 

    The literature on peripheral arterial embolism has been reviewed. Twenty cases of embolisms in 11 patients treated at the University Hospital ‘General Calixto García’ are reported. A case of embolism dislodged from an arteriosclerotic plague localized in the thoracic aorta is...

  • CONSERVATIVE TREATMENT AND RECOVERY IN TWO CASES OF AORTIC EMBOLISM. Milwidsky, H.; Ehrenfeld, E. N.; DeVries, A. // Angiology;Aug1952, Vol. 3 Issue 4, p275 

    Two cases of aortic saddle embolism which recovered under conservative treatment are reported. The rationale of conservative therapy with repeated sympathetic procain blocks and anticoagulants and its indications are discussed.

  • Low-Intensity Warfarin Anticoagulation Revisited. Zepf, Bill // American Family Physician;3/1/2004, Vol. 69 Issue 5, p1272 

    Discusses research being done on the use of low-intensity warfarin anticoagulation in patients with a history of deep venous thrombosis or pulmonary embolism. Reference to study by C. Kearon and colleagues, published in the August 14, 2003 issue of the "New England Journal of Medicine";...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics